FTRP Field Trip Health Ltd
- 1.090
- 0.0000.00%
Field Trip Health Ltd News
Reunion Neuroscience Inc. (Formerly Field Trip Health Ltd.) Reports Fiscal First Quarter 2023 Financial Results, Completed Corporate Reorganization on August 11, 2022
Completed corporate reorganization, separating the Field Trip Discovery and Field Trip Health divisions into two separate companies.Field Trip Discovery renamed Reunion Neuroscience Inc. ("Reunion" or
Reunion Neuroscience Inc. (Formerly Field Trip Health Ltd.) Reports Fiscal 1Q 2023 Fincl Results, Completed Corporate Reorganization on Aug 11
Reunion Neuroscience Inc. (Formerly Field Trip Health Ltd.) Reports Fiscal 1Q 2023 Fincl Results, Completed Corporate Reorganization on Aug 11
Field Trip Health Ltd. (FTRP) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
Field Trip Health Ltd. (FTRP - Free Report) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2022. This widely
Field Trip Health Ltd. Schedules Fiscal First Quarter 2023 Conference Call for Tuesday, August 16, 2022, at 8:30 AM ET
TORONTO, Aug. 08, 2022 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP, Nasdaq: FTRP) ("Field Trip" or the "Company"), a global leader in the development and delivery of psychedelic therapies,
Field Trip Health Ltd. Gets Conditional Approval for Listing of Common Shares of Field Trip Health & Wellness Ltd. on the TSX Venture Exchange
06:16 AM EDT, 08/05/2022 (MT Newswires) -- Field Trip Health Ltd. (TSX: FTRP, Nasdaq: FTRP), a global player in the development and delivery of psychedelic therapies, announced overnight Thursday that
Field Trip Health Ltd. Receives Conditional Approval for Listing of Common Shares of Field Trip Health & Wellness Ltd. on the TSX Venture Exchange
– Field Trip Health & Wellness Ltd. to list on the TSX Venture Exchange, with first day of trading expected to occur on or about August 17, 2022. – Field Trip Discovery to be renamed Reunion Neuroscience Inc., remaining listed on the NASDAQ Stock
BRIEF-Field Trip Health Ltd Announces Intention To Separate The Field Trip Discovery And Field Trip Health Divisions Into Two Independent Public Companies
April 28 (Reuters) - Field Trip Health Ltd FTRP.TO :* . ANNOUNCES INTENTION TO SEPARATE THE FIELD TRIP DISCOVERY AND FIELD TRIP HEALTH DIVISIONS INTO TWO INDEPENDENT PUBLIC COMPANIES* SHAREHOLDERS OF
Field Trip Health Ltd. Granted US Patent Covering Novel Psychedelic Molecule FT-104
The Allowed Claims include Composition of FT-104 and Provides Protection until 2040TORONTO, April 05, 2022 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (NASDAQ: FTRP, TSX: FTRP) ("Field Trip"), a glob
Field Trip Health Ltd. CEO Joseph Del Moral on Q3 2022 -- Earnings Call Transcript >FTRP
From Seeking Alpha: Field Trip Health Ltd. CEO Joseph Del Moral on Q3 2022 -- Earnings Call Transcript
Press Release: Field Trip Health Ltd. Reports -3-
SOURCE Field Trip Health Ltd.
A number of insiders bought Field Trip Health Ltd. (TSE:FTRP) stock last year, which is great news for shareholders
It is usually uneventful when a single insider buys stock. However, When quite a few insiders buy shares, as it happened in Field Trip Health Ltd.'s (TSE:FTRP) case, it's fantastic news for shareholde
Press Release: Field Trip Health Ltd. Reports -2-
Net loss for the second fiscal quarter of $13,019,280 was primarily due to total operating costs of $15,638,596, of which $2,055,890 was related to non-cash share-based compensation and $848,712 wa
Hot Stocks: Psychedelics get higher; MSFT crowned; ZEN merger booed; TARO faces deflation; X rallies
Bad news for Apple and Amazon turned into good news for Microsoft (NASDAQ:MSFT) on Friday. While two of the software giant's megacap rivals suffered earnings-inspired declines, MSFT rose to a new 52
Psyched: British PM Considers Psychedelics, New Partnership To Study Psilocybin For Autism, Compass Gets Another Patent
The Week In Psychedelics British Prime Minister Boris Johnson To Consider Psilocybin Legalization Nova Mentis and Mycrodose Partner To Research Psilocybin For Autism Fourth Massachusetts City Decrimin
This Psychedelic Therapies Stock Has A Better One-Year Return Than Nio, AMD, Nvidia And GE
Field Trip Health Ltd (NASDAQ:FTRP) is a global leader in psychedelic therapies, and over the past year, bringing eye-popping gains to investors’ portfolios. Since October 2020, Field Trip Health stoc
